Insmed (INSM) Misses Q1 EPS by 4c ; Offers Guidance
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $102.41 +3.85%
Revenue Growth %: +264.2%
Financial Fact:
Interest expense: -769K
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +264.2%
Financial Fact:
Interest expense: -769K
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($1.17), $0.04 worse than the analyst estimate of ($1.13). Revenue for the quarter came in at $65.2 million versus the consensus estimate of $63.93 million.
GUIDANCE:
Insmed sees FY2023 revenue of $285-300 million, versus the consensus of $293 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
- Goldman "broadly" raises estimates for LTL and truckload stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
